FibroGen, Inc
Symbol: FGEN (NASDAQ)
12.26
▲ (0.08%) 0.010
Company Description:
FibroGen Inc is a biotechnology company focused on discovering, developing, and commercializing novel therapeutics to treat serious cancer biology and anemia. The company operates in one reportable segment: the development and commercialization of novel therapeutics to treat serious unmet medical needs. The company generates the vast majority of its revenue in Europe, followed by Japan. Virtually all of FibroGen's revenue to date has been generated from its collaboration agreements. FibroGen seeks partners with research, development, and marketing capabilities and other resources that strengthen the company's ability to advance product candidates. Geographically, it operates in United States, Japan, Europe and Others.
Key Stats
- Today's Open: $12.27
- Today's High: $12.33
- Today's Low: $11.975
- Today's Volume: 12.10K
- Yesterday Close: $12.245
- Yesterday High: $12.58
- Yesterday Low: $12.06
- Yesterday Volume: 30.50K
- Last Min Volume: 20
- Last Min High: $12.255
- Last Min Low: $12.159
- Last Min VWAP: $12.159
Company Profile
- Name: FibroGen, Inc
- Website: https://www.fibrogen.com
- Listed Date: 2014-11-14
- Location: SAN FRANCISCO, CA
- Market Status: Active
- CIK Number: 0000921299
- SIC Code: 2834
- SIC description: PHARMACEUTICAL PREPARATIONS
- Market Cap: $49.52M
- Round Lot: 100
- Outstanding Shares: 4.04M
- Asset Type: CS
RECENT FILINGS FOR FGEN
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-09-09 | 4 | View |
| 2025-09-09 | 4 | View |
| 2025-09-05 | 8-K | View |
| 2025-09-02 | 8-K | View |
| 2025-08-18 | 8-K | View |
| 2025-08-15 | SCHEDULE 13G/A | View |
| 2025-08-14 | 8-K | View |
| 2025-08-11 | 10-Q | View |
| 2025-08-11 | 8-K | View |
| 2025-07-29 | SCHEDULE 13G/A | View |
| 2025-07-14 | 8-K | View |
| 2025-07-02 | 4 | View |
| 2025-06-13 | 8-K | View |
| 2025-06-12 | 8-K | View |
| 2025-06-09 | 8-K | View |
| 2025-06-06 | 4 | View |
| 2025-06-06 | 4 | View |
| 2025-06-06 | 4 | View |
| 2025-06-06 | 4 | View |
| 2025-06-06 | 3 | View |
Latest News on FGEN